This website is for Healthcare Professionals


Report Adverse Event

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.

Adverse events should also be reported to AbbVie at:

ABBV-RO-00032-MC.   Date of preparation: December 2020